Dr Martens’ sales and profits rise in IPO year
Footwear retailer and brand Dr Martens has reported increased sales and profits for the year that brought its IPO.
Dr Martens chief executive Kenny Wilson said the performance demonstrated “resilience, dedication and agility” in the face of the pandemic, which disrupted retail operations.
Dr Martens’ revenue climbed 15% to £773m in the year to March 31, when pre-tax profits before exceptionals rose 34% to £151.4m.
One-off costs, such as the IPO and a £49 bonus for all employees, brought pre-tax profits down 30% to £70.9m.
Already have an account? Sign in here